Understanding of G protein-coupled odorant receptors function

了解 G 蛋白偶联气味受体功能

基本信息

  • 批准号:
    10093004
  • 负责人:
  • 金额:
    $ 8.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-02-01 至 2022-04-30
  • 项目状态:
    已结题

项目摘要

Abstract: The strategy used by our brain to detect and make sense of its volatile environment is olfaction. Olfactory perception begins with the interaction of odorants with odorant receptors (OR) expressed by olfactory sensory neurons (OSN). Odor recognition follows a combinatorial coding scheme, where one OR can be activated by a set of odorants and one odorant can activate a combination of ORs. Through such combinatorial coding, organisms can detect and discriminate between a myriad of volatile odor molecules. Thus, an odor at a given concentration can be described by an activation pattern of ORs, which is specific to each odor. In that sense, cracking the mechanisms that the brain uses to perceive odor requires the understanding odorant-OR interactions. In the G protein coupled receptor family (GPCR), the rhodopsin class contains the subfamily associated with odor perception, the ORs. GPCRs are essential in pharmacology since they represent a third of the drug target. Their structural determination, such as for the beta 2 adrenergic receptor, has helped understanding how drugs interact with their target. Despite ORs represent nearly a half of the GPCR family with 400 different members in humans, none has been structurally elucidated, notably due to their challenging expression in cell systems. Theoretical structures of ORs built by homology with non-olfactory GPCRs are currently state-of-the-art to gain fundamental knowledge on OR function. Such models will strongly benefit from an OR structure template. Using the diversity of the OR repertoire, I will design new odorant receptors called "consensus ORs". Their expression and mechanisms of activation and inhibition will be comparable to structurally elucidated non-olfactory GPCR. I will thus obtain a performant set of ORs, which will be subjected to in silico and in vitro approaches. This transdisciplinary research strategy will include molecular modeling, functional assays, site-directed mutagenesis, protein production and purification. It is of central importance to identify general mechanisms governing the function of ORs and GPCRs in general. It will allow describing odorant-OR interaction with unprecedented level of details, as well as understanding the strategy our brain uses to perceive its olfactory environment.
翻译后摘要:我们的大脑使用的策略来检测和理解其不稳定的环境是嗅觉。 嗅觉感知开始于气味与嗅觉细胞表达的气味受体(OR)的相互作用。 感觉神经元(OSN)。气味识别遵循组合编码方案,其中一个OR可以是 由一组气味剂激活,并且一种气味剂可以激活OR的组合。通过这种组合 通过编码,生物体可以检测和区分无数的挥发性气味分子。因此,一种气味 给定的浓度可以通过OR的激活模式来描述,这对每种气味都是特异性的。在这 在感官上,破解大脑用来感知气味的机制需要理解气味-或 交互.在G蛋白偶联受体家族(GPCR)中,视紫红质类包含亚家族 与气味感知相关的器官GPCR在药理学中是必不可少的,因为它们代表了三分之一 的药物靶点。它们的结构决定,如β 2肾上腺素能受体, 了解药物如何与其靶点相互作用。尽管OR代表了GPCR家族的近一半 在人类中有400个不同的成员,没有一个在结构上被阐明,特别是由于它们的挑战性, 在细胞系统中表达。通过与非嗅觉GPCR的同源性构建的OR的理论结构是 目前最先进的技术,以获得关于OR功能的基础知识。这种模式将大大受益于 OR结构模板。利用手术室的多样性,我将设计新的气味受体, “共识OR”。它们的表达以及激活和抑制机制将与 结构阐明的非嗅觉GPCR。因此,我将获得一组性能良好的OR, to in silico硅片and in vitro体外approaches方法.这种跨学科的研究策略将包括分子建模, 功能测定、定点诱变、蛋白质生产和纯化。至关重要的是 确定管理OR和GPCR功能的一般机制。它将允许描述 气味或互动与前所未有的细节水平,以及了解我们的大脑的策略, 用来感知嗅觉环境

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Decoding the olfactory map through targeted transcriptomics links murine olfactory receptors to glomeruli.
  • DOI:
    10.1038/s41467-022-32267-3
  • 发表时间:
    2022-09-01
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Zhu, Kevin W.;Burton, Shawn D.;Nagai, Maira H.;Silverman, Justin D.;de March, Claire A.;Wachowiak, Matt;Matsunami, Hiroaki
  • 通讯作者:
    Matsunami, Hiroaki
A chemical signal in human female tears lowers aggression in males.
  • DOI:
    10.1371/journal.pbio.3002442
  • 发表时间:
    2023-12
  • 期刊:
  • 影响因子:
    9.8
  • 作者:
    Agron, Shani;de March, Claire A.;Weissgross, Reut;Mishor, Eva;Gorodisky, Lior;Weiss, Tali;Furman-Haran, Edna;Matsunami, Hiroaki;Sobel, Noam
  • 通讯作者:
    Sobel, Noam
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Claire A. de March其他文献

Decoding the olfactory map: targeted transcriptomics link olfactory sensory neurons to glomeruli
解码嗅觉图谱:靶向转录组学将嗅觉感觉神经元与肾小球联系起来
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kevin W. Zhu;S. Burton;Maíra H. Nagai;J. Silverman;Claire A. de March;M. Wachowiak;H. Matsunami
  • 通讯作者:
    H. Matsunami
Decoding the olfactory map: targeted transcriptomics link olfactory receptors to glomeruli
解码嗅觉图谱:靶向转录组学将嗅觉受体与肾小球联系起来
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kevin W. Zhu;S. Burton;Maíra H. Nagai;J. Silverman;Claire A. de March;M. Wachowiak;H. Matsunami
  • 通讯作者:
    H. Matsunami
Divergence from conserved residues underlies intracellular retention of mammalian odorant receptors
与保守残基的分歧是哺乳动物气味受体细胞内保留的基础
  • DOI:
    10.1101/605337
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kentaro Ikegami;Claire A. de March;Maíra H. Nagai;Soumadwip Ghosh;Matthew Do;Ruchira Sharma;Elise S. Bruguera;Y. Lu;Yosuke Fukutani;N. Vaidehi;M. Yohda;H. Matsunami
  • 通讯作者:
    H. Matsunami
Engineered odorant receptors illuminate the basis of odour discrimination
工程化气味受体揭示了气味辨别基础
  • DOI:
    10.1038/s41586-024-08126-0
  • 发表时间:
    2024-10-30
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Claire A. de March;Ning Ma;Christian B. Billesbølle;Jeevan Tewari;Claudia Llinas del Torrent;Wijnand J. C. van der Velden;Ichie Ojiro;Ikumi Takayama;Bryan Faust;Linus Li;Nagarajan Vaidehi;Aashish Manglik;Hiroaki Matsunami
  • 通讯作者:
    Hiroaki Matsunami

Claire A. de March的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
  • 批准号:
    24K12256
  • 财政年份:
    2024
  • 资助金额:
    $ 8.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
  • 批准号:
    24K19176
  • 财政年份:
    2024
  • 资助金额:
    $ 8.62万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 8.62万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 8.62万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 8.62万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 8.62万
  • 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
  • 批准号:
    10734158
  • 财政年份:
    2023
  • 资助金额:
    $ 8.62万
  • 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
  • 批准号:
    10784209
  • 财政年份:
    2023
  • 资助金额:
    $ 8.62万
  • 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
  • 批准号:
    10580259
  • 财政年份:
    2023
  • 资助金额:
    $ 8.62万
  • 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
  • 批准号:
    23K05057
  • 财政年份:
    2023
  • 资助金额:
    $ 8.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了